Biology:NAB2
Generic protein structure example |
NGFI-A-binding protein 2 also known as EGR-1-binding protein 2 or melanoma-associated delayed early response protein (MADER) is a protein that in humans is encoded by the NAB2 gene.[1][2][3]
Function
This gene encodes a member of the family of NGFI-A binding (NAB) proteins, which function in the nucleus to repress or activate transcription induced by some members of the EGR (early growth response) family of transactivators. NAB proteins can homo- or hetero-multimerize with other EGR or NAB proteins through a conserved N-terminal domain, and repress transcription through two partially redundant C-terminal domains. Transcriptional repression by the encoded protein is mediated in part by interactions with the nucleosome remodeling and deactylase (NuRD) complex. Alternatively spliced transcript variants have been described, but their biological validity has not been determined.[3]
Pathology
Recurrent somatic fusions of the two genes, NGFI-A–binding protein 2 (NAB2) and STAT6, located at chromosomal region 12q13, have been identified in solitary fibrous tumors.[4]
References
- ↑ "NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by proliferative and differentiative stimuli". Molecular and Cellular Biology 16 (7): 3545–3553. August 1996. doi:10.1128/MCB.16.7.3545. PMID 8668170.
- ↑ "Mader: a novel nuclear protein over expressed in human melanomas". Oncogene 12 (5): 963–971. July 1996. PMID 8649813.
- ↑ 3.0 3.1 "Entrez Gene: NAB2 NGFI-A binding protein 2 (EGR1 binding protein 2)". https://www.ncbi.nlm.nih.gov/gene?Db=gene&Cmd=ShowDetailView&TermToSearch=4665.
- ↑ "Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer". Journal of Clinical Oncology 23 (16): 3706–3712. June 2005. doi:10.1200/JCO.2005.00.232. PMID 15867200.
Further reading
- "The Nab2 and Stat6 genes share a common transcription termination region". Genomics 41 (1): 33–39. April 1997. doi:10.1006/geno.1997.4609. PMID 9126479.
- "The transcriptional corepressor NAB2 inhibits NGF-induced differentiation of PC12 cells". The Journal of Cell Biology 142 (4): 1075–1082. August 1998. doi:10.1083/jcb.142.4.1075. PMID 9722618.
- "Novel mutants of NAB corepressors enhance activation by Egr transactivators". The EMBO Journal 17 (20): 6010–6019. October 1998. doi:10.1093/emboj/17.20.6010. PMID 9774344.
- "Impaired prostate tumorigenesis in Egr1-deficient mice". Nature Medicine 7 (1): 101–107. January 2001. doi:10.1038/83231. PMID 11135623.
- "Frequent and early loss of the EGR1 corepressor NAB2 in human prostate carcinoma". Human Pathology 32 (9): 935–939. September 2001. doi:10.1053/hupa.2001.27102. PMID 11567222.
- "Search for mutations in the EGR2 corepressor proteins, NAB1 and NAB2, in human peripheral neuropathies". Neurogenetics 4 (1): 37–41. March 2002. doi:10.1007/s10048-001-0124-2. PMID 12030330.
- "NAB2, a corepressor of EGR-1, inhibits vascular endothelial growth factor-mediated gene induction and angiogenic responses of endothelial cells". The Journal of Biological Chemistry 278 (13): 11433–11440. March 2003. doi:10.1074/jbc.M204937200. PMID 12427750.
- "Egr-1 induces the expression of its corepressor nab2 by activation of the nab2 promoter thereby establishing a negative feedback loop.". The Journal of Biological Chemistry 280 (52): 42785–42793. 2005. doi:10.1074/jbc.M511079200. PMID 16260776.
- "Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes". Genome Research 16 (1): 55–65. January 2006. doi:10.1101/gr.4039406. PMID 16344560.
- "NAB2 represses transcription by interacting with the CHD4 subunit of the nucleosome remodeling and deacetylase (NuRD) complex". The Journal of Biological Chemistry 281 (22): 15129–15137. June 2006. doi:10.1074/jbc.M600775200. PMID 16574654.
- "Global, in vivo, and site-specific phosphorylation dynamics in signaling networks". Cell 127 (3): 635–648. November 2006. doi:10.1016/j.cell.2006.09.026. PMID 17081983.
